AnticoagEvaluator vs Anticoagulation Guidelines
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
AnticoagEvaluator
This medical app assists healthcare professionals in making informed decisions regarding antithrombotic therapy for patients with non-valvular atrial fibrillation. It calculates patient risk factors, provides guideline-driven therapy recommendations, and helps optimize anticoagulant dosages.
- Calculate renal function and stroke/bleed risk
- Review ACC/AHA/HRS guideline therapy
- Generate individualized antithrombotic risk
- Optimize DOAC dosages
- Based on SPARC Tool
Read full descriptionHide full description
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator. Use the app to: • Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed • Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention • Generate individualized risk for antithrombotic therapy options based on individual clinical trials. • Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics. This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
Anticoagulation Guidelines
This application helps residents and fellows determine when to discontinue anticoagulant and antiplatelet medications before medical procedures. It provides guidance on holding these drugs to ensure patient safety during interventions.
- Hold anticoagulant drugs
- Hold antiplatelet drugs
- Procedure drug timing
- Medical resident guidance
- Fellowship medical tool
Read full descriptionHide full description
This app if for Dr. Bernstein's residents and fellows to know when to stop anticoagulant and antiplatelet drugs prior to procedures.
Screenshots
Verdict
The clearest difference is rating: Anticoagulation Guidelines at 5.0 against AnticoagEvaluator's 2.3. Anticoagulation Guidelines also leads on iOS requirement (9.0 vs 11.0). AnticoagEvaluator's advantage is ratings volume (3 vs 1). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Anticoagulation Guidelines holds the better App Store score, 5.0 against 2.3. Both are backed by a comparable volume of ratings — 3 and 1 respectively.
| Parameter | AnticoagEvaluator | Anticoagulation Guidelines |
|---|---|---|
| Price | Free | Free |
| Rating | 2.3 (3 ratings) | 5.0 (1 ratings) — better |
| Positive reviews | 30.0% of reviews | — |
| Number of ratings | 3 — better | 1 |
| Update frequency | Every 7 months | — |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 11.0 | 9.0 — better |
| Further details — not scored | ||
| Size | 25 MB | 14 MB |
| Age rating | 17+ | 4+ |
| Developer | American College of Cardiology | aaron sobol |
Customer experience
AnticoagEvaluator
Anticoagulation Guidelines
In-app purchases
AnticoagEvaluator
No in-app purchases
Anticoagulation Guidelines
No in-app purchases
Questions
Is AnticoagEvaluator free?
Is Anticoagulation Guidelines free?
Which has better reviews, AnticoagEvaluator or Anticoagulation Guidelines?
Do AnticoagEvaluator or Anticoagulation Guidelines have ads?
Other comparisons
